Fulcrum Therapeutics (FULC) Prepaid Assets (2018 - 2026)
Fulcrum Therapeutics' (FULC) quarterly Prepaid Assets came in at $5.4 million in Q1 2026, up 7.62% year-on-year from $5.0 million in Q1 2025, and up 3.46% on a QoQ basis from $5.2 million in Q4 2025.
Fulcrum Therapeutics (FULC) Prepaid Assets (2018 - 2026) Analysis & Trends
Fulcrum Therapeutics (FULC) has 9 years of Prepaid Assets data on file, last reported at $5.4 million in Q1 2026.
- On a quarterly basis, Prepaid Assets rose 7.62% year-over-year to $5.4 million in Q1 2026; TTM through Mar 2026 was $5.4 million, a 7.62% increase from a year earlier, with the FY2025 full-year figure at $5.2 million, down 23.98% from the prior year.
- Prepaid Assets for Q1 2026 stood at $5.4 million, up from $5.2 million in the prior quarter.
- Over the last five years, Prepaid Assets for FULC reached as high as $6.8 million in Q4 2024 and fell as low as $4.1 million in Q2 2023.
- Historically, Prepaid Assets has averaged $5.0 million across 5 years, with a median of $5.0 million in 2025.
- Across the five-year window, Prepaid Assets jumped 37845.45% in 2022 and declined 23.98% in 2025, its largest moves.
- Year by year, Prepaid Assets stood at $4.4 million in 2022, then climbed by 24.54% to $5.4 million in 2023, then gained by 25.09% to $6.8 million in 2024, then retreated by 23.98% to $5.2 million in 2025, then advanced by 3.46% to $5.4 million in 2026.
- Per Business Quant data, the three most recent Prepaid Assets figures were $5.4 million in Q1 2026, $5.2 million in Q4 2025, and $5.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Fulcrum Therapeutics | 285.43 Mn | 285.43 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.35 Mn |
| Dec 31, 2025 | 5.17 Mn |
| Sep 30, 2025 | 5.22 Mn |
| Jun 30, 2025 | 5.26 Mn |
| Mar 31, 2025 | 4.97 Mn |
| Dec 31, 2024 | 6.81 Mn |
| Sep 30, 2024 | 6.60 Mn |
| Jun 30, 2024 | 4.18 Mn |
| Mar 31, 2024 | 4.64 Mn |
| Dec 31, 2023 | 5.44 Mn |
| Sep 30, 2023 | 4.82 Mn |
| Jun 30, 2023 | 4.13 Mn |
| Mar 31, 2023 | 4.89 Mn |
| Dec 31, 2022 | 4.37 Mn |
| Sep 30, 2022 | 5.14 Mn |
| Jun 30, 2022 | 4.17 Mn |
| Mar 31, 2022 | 4.15 Mn |
| Dec 31, 2021 | 4.20 Mn |
| Sep 30, 2021 | 4.67 Mn |
| Jun 30, 2021 | 11,000.00 |